Comparison of PMH (1) and pemoline activity after electroconvulsive shock.
D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects*; D003213:Conditioning, Psychological / Q000187:drug effects; D004357:Drug Synergism; D004597:Electroshock; D006801:Humans; D008277:Magnesium Oxide / Q000494:pharmacology*; D008569:Memory Disorders / Q000188:drug therapy; D008722:Methods; D051379:Mice; D010389:Pemoline / Q000008:administration & dosage / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012640:Seizures / Q000517:prevention & control*
D008277:Magnesium Oxide; D010389:Pemoline